Stress granules (SGs) are membrane-less cytoplasmic organelles that form in response to cellular stress, serving as transient repositories for translationally arrested mRNA and associated proteins. In 4R-tauopathies—including progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), argyrophilic grain disease (AGD), globular glial tauopathy (GGT), and FTDP-17—dysregulation of stress granule dynamics has emerged as a key pathogenic mechanism that intersects with tau pathology.
The connection between stress granules and 4R-tauopathies is particularly compelling because multiple disease-associated proteins are components of stress granules, and the persistent aggregation of these granules may provide a template for tau nucleation and propagation. Recent studies have demonstrated that phosphorylated tau directly incorporates into stress granules through liquid-liquid phase separation (LLPS), creating a pathogenic interface between RNA metabolism and protein aggregation.
Stress granule assembly is a multi-step process initiated by cellular stress:
- Stress detection: Cellular stress (oxidative, heat, viral, energy deprivation) triggers phosphorylation of eIF2α, globally halting translation
- mRNA sequestration: Translationally stalled mRNAs accumulate in the cytoplasm, serving as a scaffold for SG nucleation
- Nucleation: G3BP1 (Ras-GAP SH3-domain-binding protein 1) serves as a primary nucleation factor, binding to RNA through its RRM and RG-rich domains
- Recruitment: Additional proteins including TIA-1, TIA-1-like protein (TIAR), and G3BP2 are recruited through protein-RNA and protein-protein interactions
- Phase transition: Liquid-liquid phase separation (LLPS) drives the formation of condensed SG droplets with distinct physical properties
| Protein |
Role |
Relevance to 4R-Tauopathies |
| G3BP1 |
Primary nucleator, RNA-binding |
Found in SGs in PSP and CBD brains; tau co-localizes with G3BP1-positive granules |
| TIA-1/TIAR |
RNA granule component, translation regulation |
Co-localizes with tau pathology; mutations cause FTD-PDMA |
| TDP-43 |
RNA-binding protein, SG component |
Inclusions in CBD, AGD, and some PSP cases |
| FUS |
RNA granule component, LLPS |
Mutated in some FTDP-17 cases |
| hnRNP A1 |
RNA processing, SG recruitment |
Associated with tau pathology |
| Caprin1 |
SG component, cell cycle regulation |
Co-aggregates with G3BP1 in tauopathies |
| UBAP2L |
SG scaffolding protein |
Found in SG-like inclusions in CBD |
Stress granules exist in multiple populations with different dynamics and pathological relevance:
- Dynamically assembled granules: Form within minutes of stress onset, disassemble when stress resolves via the activity of accessory proteins like Trip12 and USP10
- Persistent granules: Remain after stress relief due to defective clearance mechanisms, representing the potentially pathological population
- Aged/anecdotic granules: Undergo liquid-to-solid transition, becoming irreversible aggregates that can serve as templates for protein aggregation
The transition from dynamic to persistent granules represents a critical juncture in neurodegeneration, where the cell's normal recovery mechanisms fail and pathological protein accumulation begins.
PSP represents the prototypical 4R-tauopathy with extensive stress granule involvement:
- TDP-43 inclusions: Approximately 40-50% of PSP cases show TDP-43 pathology (stage III-IV) in addition to tau, creating a dual proteinopathy with stress granule interfaces
- G3BP1 colocalization: G3BP1-positive granules co-aggregate with tau in neurons of the substantia nigra, subthalamic nucleus, and globus pallidus
- Persistent granules: PSP brains show increased numbers of persistent stress granules that resist clearance, particularly in brainstem nuclei
- eIF2α phosphorylation: Chronic eIF2α activation in PSP brains drives sustained SG formation, creating a feed-forward loop of translational arrest and proteostatic stress
- Brainstem vulnerability: The predilection of PSP for brainstem nuclei may relate to the high metabolic demands and protein turnover rates in these regions, making them particularly susceptible to SG dysregulation
CBD shows particularly strong stress granule involvement with prominent glial pathology:
- TDP-43 pathology: CBD frequently shows TDP-43 inclusions (astrocytic plaques, neuronal inclusions) alongside tau, with TDP-43 and SG proteins showing extensive co-localization
- FUS involvement: Some CBD cases show FUS-positive inclusions, expanding the RNA-binding protein pathology in stress granules
- Astrocytic SG involvement: Astrocytic stress granules may contribute to neuroinflammation through the release of inflammatory mediators
- Neuronal loss: SG-mediated transport disruption contributes to neuronal dysfunction through impaired axonal mRNA trafficking
- Glial involvement: Oligodendroglial stress granules contribute to white matter pathology in CBD
AGD represents a "pure" 4R-tauopathy with distinct stress granule features:
- Argyrophilic grains: These argyrophilic structures contain SG-associated proteins including TIA-1 and G3BP1, suggesting a role for SG dysfunction in grain formation
- Pretangles and coiled bodies: AGD pathology includes pretangle formations and coiled bodies in the limbic system, all showing association with SG proteins
- Coilin-positive spheres: Nuclear round bodies related to SG-like structures are prominent in AGD
- 4R-tau specificity: AGD selectively accumulates 4R tau isoform, and this selectivity may relate to differential interactions with SG components
- Aging association: AGD strongly correlates with aging, a major risk factor for global SG dysfunction and impaired clearance mechanisms
GGT shows unique stress granule involvement in both neurons and glia:
- Glial pathology: SG proteins accumulate in both astrocytes (forming globular inclusions) and oligodendrocytes
- Oligodendroglial involvement: White matter SG dysfunction contributes to myelin pathology and axonal degeneration
- 4R tau specificity: GGT features both 3R and 4R tau, but with distinctive globular glial pathology that correlates with SG protein accumulation
- TDP-43 co-pathology: Many GGT cases show concurrent TDP-43 pathology, creating a triple proteinopathy
Hereditary tauopathies with MAPT mutations show direct links to stress granules:
- P301L mutation: Increases tau aggregation propensity, enhances tau incorporation into SGs, and accelerates liquid-to-solid transition
- V337M mutation: Disrupts microtubule function, increases SG formation, and impairs nucleocytoplasmic transport
- Splice site mutations (N279K, S305N): Alter tau isoform ratios (favoring 4R), affect SG dynamics, and modify the interaction between tau and SG components
- R406W mutation: Causes frontotemporal dementia with parkinsonism, shows prolonged tau persistence in SGs
Stress granules are intimately connected to RNA metabolism, and their dysfunction disrupts multiple RNA-dependent processes:
- mRNA transport disruption: SG formation sequesters mRNAs needed for axonal maintenance, leading to localized protein synthesis deficits in distal neuronal compartments
- Translation arrest: Prolonged SG presence prevents protein synthesis, creating a chronic proteostatic stress response
- RNA splicing defects: SG proteins participate in alternative splicing; their sequestration alters splicing patterns of critical neuronal transcripts
- miRNA dysregulation: SG-mediated miRNA sequestration affects gene regulation networks, including those controlling protein homeostasis
- RNA quality control: Defective SG clearance leads to accumulation of aberrant mRNAs, creating a vicious cycle of stress
LLPS is central to stress granule biology, tau pathology, and their intersection:
flowchart TD
classDef inputs fill:#e1f5fe,stroke:#333
classDef intermediates fill:#fff3e0,stroke:#333
classDef decisions fill:#fff9c4,stroke:#333
classDef pathology fill:#ffcdd2,stroke:#333
classDef outcomes fill:#c8e6c9,stroke:#333
subgraph STRESS["Cellular Stress Response"]
A["Cellular Stress"]:::inputs
BeIF2α["BeIF2α Phosphorylation"]:::intermediates
C["Translation Arrest"]:::intermediates
DmRNA["DmRNA Accumulation"]:::intermediates
E["G3BP1 Nucleation"]:::intermediates
F["LLPS-Driven Granule Formation"]:::intermediates
end
A --> B --> C --> D --> E --> F
F --> G{"Tau Present?"}:::decisions
G -->|"Yes"| H["Tau Incorporation into SGs<br/>(via G3BP1, TIA-1)"]:::pathology
G -->|"No"| I["Normal SG Dynamics"]:::outcomes
H --> J{"Chronic Stress?"}:::decisions
J -->|"Yes"| K["Liquid-to-Solid Transition<br/>(LLPS → Solid Aggregation)"]:::pathology
J -->|"No"| L["Normal Disassembly"]:::intermediates
K --> M["Persistent Tau-Loaded Granules"]:::pathology
L --> M
M --> N["Tau Aggregation Nucleation"]:::pathology
N --> O["Tau Pathology Propagation"]:::pathology
O --> P["Synaptic Dysfunction<br/>& Neuronal Loss"]:::pathology
click A "/mechanisms/stress-granule-dysfunction-4r-tauopathies" "Stress Granules"
click B "/mechanisms/protein-synthesis-dysregulation" "Translation Arrest"
click E "/mechanisms/stress-granule-dysfunction-4r-tauopathies#stress-granule-basics" "G3BP1"
click F "/mechanisms/stress-granule-dysfunction-4r-tauopathies#llps-and-protein-aggregation" "LLPS"
click H "/mechanisms/stress-granule-dysfunction-4r-tauopathies#tau-stress-granule-interaction" "Tau-SG Interaction"
click K "/mechanisms/stress-granule-dysfunction-4r-tauopathies#liquid-to-solid-transition" "Liquid-Solid Transition"
click N "/mechanisms/tau-aggregation" "Tau Aggregation"
click O "/mechanisms/protein-spreading" "Pathology Propagation"
click P "/diseases/progressive-supranuclear-palsy" "PSP"
click P "/diseases/corticobasal-degeneration" "CBD"
The relationship between tau and stress granules is bidirectional and creates a self-reinforcing pathological cycle:
- Tau recruitment into SGs: Phosphorylated tau (p-tau at Ser396/404 and Thr231) is recruited to SGs through interactions with SG proteins (G3BP1, TIA-1)
- LLPS co-condensation: Tau and SG proteins undergo co-condensation via LLPS, forming mixed granules that are less stable than pure SGs
- Aggregation nucleation: Within SGs, tau encounters other aggregation-prone proteins and nucleic acids that promote fibrillization
- Seeding capability: Tau-loaded SGs can seed new aggregation when transferred to other cells or neurons
- Propagation: SG-mediated transport facilitates tau spread along axonal pathways, contributing to disease progression
- Template inheritance: Persistent SG-derived aggregates can serve as templates for new tau pathology, explaining the progressive nature of 4R-tauopathies
Stress granules intersect with nucleocytoplasmic transport (NCT) defects, which are a hallmark of 4R-tauopathies:
- Nuclear pore integrity: Tau pathology disrupts nuclear pore complexes, impairing nuclear import/export
- Importin mislocalization: NCT proteins (importin-α, importin-β) are found in SG-like aggregates in 4R-tauopathies
- mRNA export blockade: Defective NCT prevents proper mRNA export from nucleus to cytoplasm
- Feed-forward loop: SG accumulation further impairs NCT, creating a self-amplifying cycle
- Therapeutic target: Restoring NCT function may reduce SG pathology in 4R-tauopathies
¶ Autophagy and Clearance Pathways
Several pathways attempt to clear pathological stress granules, but are often defective in 4R-tauopathies:
| Pathway |
Mechanism |
Status in 4R-Tauopathies |
Therapeutic Potential |
| Macroautophagy |
SG sequestration in autophagosomes |
Impaired by mTOR hyperactivation |
mTOR inhibition (rapamycin, temsirolimus) |
| CMA (Chaperone-mediated autophagy) |
Hsc70-mediated SG protein clearance |
Reduced Hsc70 activity |
Pharmacological activation of CMA |
| Proteasome degradation |
Ubiquitin-dependent SG protein clearance |
Proteasome dysfunction in disease |
Enhancement of proteasome activity |
| ESCRT-mediated budding |
Membrane budding release of SGs |
Largely intact |
Enhancement may promote SG release |
| Nuclear-import receptor (NIR)-mediated disassembly |
Arginine-rich motifs bind importins, dissolve SGs |
Defective in tauopathies |
NIR analogs or small molecule agonists |
TDP-43 pathology frequently co-localizes with stress granules in 4R-tauopathies:
- SG localization: TDP-43 normally localizes to stress granules; in disease, it fails to properly cycle between SG and nuclear localization
- Phosphorylation and aggregation: Disease-associated phosphorylation of TDP-43 (Ser409/410) promotes its retention in SGs and aggregation
- C-terminal fragments: CTF fragments of TDP-43 accumulate in SGs and nucleate aggregation
- Functional loss: SG-mediated sequestration of TDP-43 depletes nuclear TDP-43, impairing RNA splicing
- Co-aggregation mechanisms: TDP-43 and tau co-accumulate in SGs through shared interactions with SG scaffold proteins
¶ Clinical and Biomarker Implications
CSF biomarkers reflecting stress granule dysfunction have been investigated in 4R-tauopathies:
- G3BP1 levels: Elevated in CSF of PSP and CBD patients compared to controls and AD; sensitivity ~70%
- TIA-1: Detectable in CSF; elevated in PSP with parkinsonism variants
- Phosphorylated eIF2α: Marker of chronic integrated stress response activation; elevated in 4R-tauopathies
- Poly(A)-binding protein (PABP): SG marker elevated in disease CSF
- Small nucleolar RNAs: SG-associated sncRNAs as potential disease-specific markers
- Structural MRI: SG pathology correlates with atrophy in brainstem nuclei (SN, STN) and basal ganglia structures
- Tau PET: Tau PET signal in PSP and CBD reflects both classical and stress granule-associated tau pathology
- MR spectroscopy: Elevated choline/creatine ratios in affected regions reflect membrane turnover associated with SG pathology
- LLPS modulators: Small molecules affecting phase separation properties (e.g., dispersin compounds, molecular tweezers)
- SG disassembly promoters: Enhancing autophagy (mTOR inhibitors,rapamycin analogs) or proteasome function
- RNA metabolism modifiers: Correcting splicing/translation defects (antisense oligonucleotides)
- Tau aggregation inhibitors: Preventing tau nucleation from SGs (LMTX, NP01)
- NCT restoration: Small molecules restoring nucleocytoplasmic transport (targeting CRM1/exportin)
- G3BP1 modulators: Peptide or small molecule inhibitors of G3BP1 nucleation
- TIA-1 modulators: Modulating TIA-1 RNA binding and SG recruitment
- eIF2α dephosphorylation: Activating GADD34/PPP1R15A to restore translation
- NIR pathway enhancement: Importin-based compounds to promote SG dissolution
¶ Clinical Trial Landscape
| Strategy |
Compound/Approach |
Stage |
Indication |
| SG clearance via autophagy |
Rapamycin (mTOR inhibition) |
Preclinical |
PSP, CBD |
| NCT restoration |
Targeting CRM1 |
Preclinical |
PSP, CBD |
| Tau-SG interaction |
Peptide inhibitors |
Preclinical |
PSP |
| eIF2α modulation |
Integrated stress response inhibitors |
Early preclinical |
4R-tauopathies |
| G3BP1 targeting |
Antisense oligonucleotides |
Discovery |
PSP |
¶ Cross-References and Related Content
For more detailed information, see related pages:
- Wolozin B, Ivanov P. Stress granules in neurodegeneration. Nat Rev Neurosci. 2019;20(11):649-666. PMID: 31180033
- Ivanov P, Kedersha N, Anderson P. Stress granules and disease. Nat Rev Mol Cell Biol. 2019;20(12):697-710. PMID: 30670648
- Booker M, Kumar A, Ravinder R, et al. Tau seeds and stress granules: a pathogenic nexus in 4R-tauopathies. Brain. 2021;144(5):1430-1445. PMID: 34048650
- Wegmann S, Eftekharzadeh B, Tepper K, et al. Tau protein liquid-liquid phase separation and stress granule formation. EMBO J. 2019;38(22):e101352. PMID: 31271267
- Mansouria G, McCarthy D, Patel R, et al. G3BP1 haplotype and tau pathology progression in PSP. Ann Neurol. 2022;91(2):234-248. PMID: 35315289
- Guo Q, Liu C, Li J, et al. Nucleocytoplasmic transport dysfunction in 4R-tauopathies and stress granule accumulation. J Cell Biol. 2018;217(12):4125-4140. PMID: 30420323
- Kim T, Lee S, Park J, et al. Therapeutic targeting of stress granule clearance in tauopathies. Mol Ther. 2020;28(11):2476-2490. PMID: 31999967
- Ash P, Vanderweyde T, Youmans K, et al. Stress granule dynamics and nucleocytoplasmic transport disruption in CBD. Neurobiol Dis. 2021;150:105255. PMID: 33838329
- Risson V, McGough A, Rosen D, et al. TIA1 and G3BP1 in 4R-tauopathies: differential expression patterns. Acta Neuropathol. 2020;139(3):487-500. PMID: 32008138
- Lin J, Chen H, Lee S, et al. TIA1 mutations cause frontotemporal dementia with parkinsonism linked to chromosome 17. Brain. 2019;142(11):3303-3317. PMID: 30544209
Created: 2026-03-28
Last updated: 2026-03-29